Soft Tissue Sarcoma with Lung Metastases Market Set to Expand Across the 7MM During the Forecast Period (2026-2036) with Advancing Targeted and Cellular Therapies | DelveInsight

The soft tissue sarcoma with lung metastases market across the 7MM is projected to demonstrate steady growth during the 2026–2036 forecast period, driven primarily by the anticipated launch of novel therapies such as Annamycin (Moleculin), IP-001 (Immunophotonics), Fibromun (Philogen),...